BRADLEY J. POWERS - 01 Apr 2023 Form 4 Insider Report for LUMOS PHARMA, INC.

Role: General Counsel
Signature: /s/ Ryan Trytten, attorney-in-fact
Issuer symbol: N/A
Transactions as of: 01 Apr 2023
Net transactions value: -$1,132
Form type: 4
Filing time: 04 Apr 2023, 17:22:40 UTC
Previous filing: 03 Feb 2023
Next filing: 05 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LUMO	Common Stock	Tax liability	$1,132	-342	-5.4%	$3.31	5,989	01 Apr 2023	Direct	F1, F2, F3, F4, F5
holding	LUMO	Common Stock						27	01 Apr 2023	By Spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of Common Stock withheld by the Issuer in satisfaction of its tax withholding obligation with respect to the vesting of 1,125 previously reported restricted stock units ("RSUs") granted to the Reporting Person.
F2	Includes 435 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person in a series of two successive annual installments with the next installment occurring on February 1, 2024, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
F3	Includes 1,125 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person on April 1, 2024, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
F4	Includes 675 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person in a series of three successive annual installments with the next installment occurring on February 1, 2024, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
F5	Includes 900 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person in a series of four successive annual installments with the next installment occurring on February 1, 2024, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.